2023-08-05T05:38:39
the permission holder shall inform the date of launch of medical
device in the market to the Central Licensing Authority;
(d) the permission holder of Form MD-27 shall submit the suspected unexpected serious adverse event within fifteen days of the awareness of the event to the Central Licensing Authority
Have a question? Ask here!
Required fields are marked *